Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Phase A - olifilcon B with Tangible Coatings
Phase B - etafilcon A with Tangible Coatings
Locations
6
United States
Ross Eyecare
Atlanta, Georgia, United States
Professional Eye Care Center
Niles, Illinois, United States
RevolutionEyes
Carmel, Indiana, United States
Andover Optometry on Central
Andover, Massachusetts, United States
Professional VisionCare
Westerville, Ohio, United States
Primary Eyecare Group, PC
Brentwood, Tennessee, United States
Start Date
March 15, 2019
Primary Completion Date
August 2, 2019
Completion Date
August 2, 2019
Last Updated
October 6, 2020
NCT05458323
NCT06996353
NCT04077086
NCT06565091
NCT05733182
NCT05670626
Lead Sponsor
Vision Service Plan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions